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Objecdres. The purpose of this study was to present follow-up
data as well as short•term results on a larger clinical series of
patients undergoing ukrasound angioplasty.
Bee
	
lei, Prevhmus OW studies have demonstrated the
Wbity of peripheral arterial ultrasound angloplasty .
Methods. We performed percutaneous ultrasound angioplasty
on 50 arterial lesions In 45 patients. Our ultrasound ablation
system had a frequency of 19 .5 kHz . A heed-wire probe with 2- or
3-mm ball tips and a 3-mm over4he-wire probe were used to tram
49 femoral, 7 popllteal and 3 tlbloperoneal lesions . Seventeen
(34%) of the lesions were calcific . Thirty (86%) of 35 occluded
segments, 0.5 to 28 c m long (mesa 6.2 t 5.7), were recacalized .
Resu t,. In the 45 patent arteries, the stenosis decreased foam
94 t 10% to 55 * 23% after ultrasound angkplesty and to 12*
8% after balloon angioplasty . Mechanical arterial dissections (n =
4) and perforations (n = 4) without clinical consequence occurred
only with the fixed ion-over-the-wire probes . No evidence of
In the past decade there has been a search for new endovas-
cular devices to resolve the major limitations of balloon
angioplasty (i .e., complete obstructions, long lesions, throm-
botic occlusions, calcified or resistant lesions and resteno-
sis). The search for new devices has resulted in a prolifera-
tion of new endovascular techniques including high speed
rotational drills or sanders, metal cutters, hydraulic cutters,
shavers, hot-tipped thermal probes, several types of hot and
cold laser irradiation methods, selective thrombolysis infu-
sion catheters and stents (1-6) .
Since 1986 we have explored the use of catheter-delivered
ultrasound for the in vitro and in vivo ablation of plaque and
thrombus in animal models with and without atherosclerosis
(7-14) . Our in vitro and in vivo animal studies, as well as the
work of other investigators (15-24), has demonstrated that
catheter-delivered ultrasound energy is 1) relatively atrau-
matic to the normal arterial wall (8-1012,14,16-23) ;
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PERIPHERAL ANGIOPLASTY
embolism or vasospasm was detected; In fact, vasodilatlon oc»
curred. There were no clinical manifestations of acute reoccluslon .
At 24 h, ankle.brachial indexes increased by 0.23 t 0.21 (range
-0.27 to 0.72). Six- to 12-month clinical and ankle-brad" index
follow-up data for 35 patients treated with ultrasound and adjunme
dve balloon angioplasty were Indicative of restenosis In 7 patients
(20%) .
Conclusions . Our findings indicate that percutaneous periph-
eral ultrasound angioplasty 1) is useful for rcanalization of
fibrous, ealdfic and thrombotic arterial occlusions; 2) reduces
arterial steneses ; and 3) has clinical and ankle-brachial index data
Indicative of a restenosis rate of 20% at 6 to 12 months In a small
cohort of patients . A larger randomized series of patients will need
to be studied to assess the impact of ultrasound ablation on
restenosis.
Q Am Coll Cardiol 1993;22.480-8)
2) generates microscopic particulate debris during recanali-
zation in vitro and in vivo that are quite small and compa-
rable to other accepted methods of recanalization (8-
19,21,22,24) ; 3) results in arterial vasodilation (14,15) ; 4)
rapidly disrupts peripheral arterial thromboses (9,11,12,16-
18,24) ; 5) recanalizes fibrous and calcific guide wire-
resistant occlusions (9-11,19,21-24); and 6) increases arte-
rial distensibility of calcific atherosclerotic lesions (11) . It is
the purpose of this report to expand on our initial clinical
experience (25) and to present the results of clinical trials of
percutaneous peripheral ultrasound angioplasty obtained
over a 2.5-year period at two different medical centers, using
a 19.5-kHz ultrasound ablation angioplasty system with two
different catheter configurations .
Methods
Ultrasound Angioplasty System
The ultrasound angioplasty ablation system (Baxter-
Edwards LIS Healthcare Corporation, Bentley Laborato-
ries, Europe B.V .) consists of a 115-V electrical generator,
piezoelectric transducer and a catheter-ensheathed
waveguide, or wire probe (Fig. 1). The transducer converts
the electrical energy into mechanical motion by piezoelectric
crystals. An acoustic horn within the transducer amplifies
the motion transmitted to a titanium wire (waveguide) that
0735-1097/931E6.00
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Figure 1. Top, Ultrasound power generator (center), foot pedal
(left), ultrasound transducer (right) and the over-the-wire probe
(waveguide) . Bottom, The two ultrasound probe tip configurations
used in the clinical trials : 3-mm ball-tipped (top) ; 3-mm ball-tipped,
monorail over-the-wire design (bottom) .
carries ultrasound energy at 19.5 kHz in the form of longi-
tudinal and transverse vibrations from the transducer to the
distal ball tip on the waveguide . With a 25-W power output
at the acoustic horn, the amplitude of longitudinal motion of
the waveguide used in this clinical series is approximately
111 µm, as measured by an optical microscope .
Figure 1 demonstrates the two different types of ultra-
sound probe configurations used in the clinical trials : the 2-
and 3-mm fixed wire ball-tipped probes and the 3-mm
ball-tipped "monorail" style over-the-wire probe that ac-
commodates a 0 .025-in . (0.064 cm) guide wire . These cath-
eter systems have ranged from 50 to 112 cm in length . The
catheter-ensheathed titanium waveguide allows crystalloid
infusion during application of ultrasound energy for cooling
as well as the performance of contrast angiography . Figure 2
illustrates the probable mechanisms of ultrasound ablation to
include a mechanical effect due to the rapid (19,500-Hz)
forward longitudinal oscillations of the probe tip, fragment-
ing plaque into microscopic particles (8), as
w;11
as the
backward movement of the probe tip, inducing microcur-
rents, pressure gradients and cavitation (1,8-14,19,21,22) .
Clinical Protocol
Patient selection . Symptomatic patients with claudication
<100 m or critical limb ischemia (rest pain, ulceration or
gangrene) were considered for therapeutic ultrasound abla-
tion if thcy fulfilled the following angiographic criteria :
1) stenosis or occlusion of superficial femoral, popliteal or
tibial artery ; 2) the presence of two-vessel distal runoff ; and
3) a lesion :515 cm . An additional three patients with lesions
> 15 cm were treated outside the protocol on a compassionate-
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Figure 2 . Schematic demonstration of the ultrasound
probe ablating
plaque or thrombus, or both . A, The probe
tip is at the lesion before
activation of ultrasound energy. B, The oscillating forward move-
ment (I I I µm) of the probe tip mechanically fragments plaque into
microscopic particles . C, The rapid (19,500 timesls) back-and-forth
movement of the probe tip induces intense microcurrents, cavitation
and pressure gradients .
use basis in an attempt to avoid peripheral vascular bypass
surgery .
Ankle-brachial index protocol . Ankle-brachial indexes
were obtained before the ultrasound procedure in 40 of 50
cases and after the procedure in 40 of 45 cases with patent
arteries . In 33 patients, the first postprocedure ankle-
brachial index was obtained at 24 h and in another 7 patients,
the initial postprocedure index was obtained at I month . In
10 of 50 cases (in 5 of which ultrasound recanalization was
not successful) no follow-up ankle-brachial index data wer°
available. In the remaining 49 of 45 cases with patent arteries
serial ankle-brachial indexes were scheduled at 6 months and
1 year unless recurrence of claudication or limb ischemia
prompted earlier follow-up study .
Angiegraphie analysis. The percent diameter stenosis be-
fore and after intervention was measured with hand-held
calipers by two experienced angiographers. To assess inter-
observer and intraobserver variability, the percent diameter
stenoses of 10 lesions were measured two times each by two
observers. The section of artery analyzed was the site of the
most severe arterial stenosis before intervention, after ultra-
sound and after adjunctive balloon angioplasty (when per-
formed). The arterial reference segment used for the deter-
mination of the percent stenosis was the largest adjacent
segment that appeared angiographically free of lumen nar-
rowing . Successful ultrasound ablation was defined as arte-
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rial recanalization of an occlusion or a ?20% increase in
lumen diameter, or both.
Ciinled follow-up. Regular clinical follow-up was per-
formed monthly as outpatient hospital visits or monthly
telephone interviews, or both, to assess the recurrence of
claudication, in which case there was a repeat outpatient
hospital visit, and physical examination and ankle-brachial
index were performed.
Angiography and ultrasound ablation procedure . Under
local lidocaine anesthesia, an 8F to 9F sheath was placed by
Seldinger technique in the superficial femoral artery for an
Lnterograde approach or in the popliteal artery for retro-
grade arterial recanalization. Baseline angiograms were per-
formed with ioxaglate contrast medium, and heparin (3,000
to 5,000 IU) was given intraarterially . The ultrasound probe
and catheter system were passed to the arterial lesion under
angiographic guidance. During passage and withdrawal of
the probe through the occlusions and stenoses, after 15 s of
activation there was a 5-s off time . To avoid potential
thermal damage from frictional forces created by the rapid
oscillations of the ultrasound probe (8), the duration of probe
activation was limited to 15 s, and there was a 5-s off time to
facilitate probe cooling. The probe was used in a pulsed
mode (30 ms on, 30 ms off), and room temperature saline
solution or crystalloid was infused at 0 .3 to 0 .5 mils. The use
of the probe under these conditions maintains probe temper-
ature at <40°C (10) .
During sonication, angiographic contrast medium was
intermittently infused to monitor the probe's progress and to
keep it intraluminal as it was advanced . After each lesion
was crossed, an angiogram was performed to assess the
residual lumen diameter, determine the need for adjunctive
balloon angioplasty and evaluate the presence of emboli in
the distal arterial bed. The application of ultrasound was
painless and required no additional analgesia or sedation
during the ultrasound Angioplasty procedure. With the early
pratotyl*, a non-over-the-wire probe system, the probe was
advanced at a rate of 1 cm every 5 to 15 s, whereas with the
over-the-wire probe, the probe was passed more slowly so
that each I cm of artery was exposed to approximately l min
of ultrasound energy, The change in the rate of probe
passage was based on experimental data demonstrating
enhanced arterial distensibility after exposure to I to 2 min
of ultrasound (13) .
All cases with a residual stenosis >50% after ultrasound
angioplasty underwent adjunctive balloon angioplasty . At
the discretion of the operator (D.C.C., J.R.C., P.G.), addi-
tional adjunctive peripheral balloon angioplasty was per-
formed using standard techniques . A final angiogram at the
end of the procedure was performed in every case to
evaluate the distal runoff and to assess the presence of
vasospasm as well as distal embolization . In the absence of
other medical conditions, patients were discharged from the
hospital the day after the ultrasound angioplasty procedure
on a regimen of 75 to 325 mg of aspirin/day .
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Clinical cases. From April 1989 to January 1992, 50
lesions in 45 patients were treated with percutaneous periph-
eral arterial ultrasound ablation . The patients' age range was
41 to 79 years ; 30 men and 15 women participated . Before
initiation of these studies, approval was obtained from the
Ethical Review Committee of Northern General Hospital
and of the Royal Hallamshire Hospital, Sheffield, England
and the Institutional Review Board of Seton Medical Center,
San Francisco Heart Institute, Daly City and of Cedars-Sinai
Medical Center, Los Angeles, California .
Baseline anglographic data . Ultrasound angioplasty was
performed in 35 arterial occlusions and 15 stenoses: 40
superficial femoral artery lesions, 7 popliteal lesions and 3
tibioperoneal lesions . For occlusions and stenoses, lesion
length was as follows: 10 lesions were 0.5 to 2 .0 cm; 20
lesions were 2.1 to 5.0 cm; 13 were 5.1 to 10 cm ; 4 were
between 10.1 and 15 cm ; and 3 occlusions were > 15 cm long .
The 35 total arterial occlusions ranged in length from 0 .5 to
28 cm (6.2 ± 5.7). Radiographic arterial calcification was
present in 17 cases. The mean baseline angiographic stenosis
was 94 ± 10%. The percent of angiographic stenosis (before
and after intervention) was measured by calipers and deter-
mined by the consensus of two observers .
Statistical analysis . Linear regression analyses were per-
formed to assess intraobserver and interobserver variability .
Comparison of angiographic diameter stenoses was per-
formed using a two-sided unpaired Student t test . p Values <
0.05 were considered significant . Data are expressed as
mean value ± SD.
Results
Anglagraphic findings. Percutaneous peripheral ultra-
sound angioplasty was performed on 50 lesions in 45 patients .
Ultrasound ablation was considered successful in 43 of the
50 lesions because 30 of the 35 totally occluded arteries were
recanalized, and 13 of the 15 stenoses were reduced by
>20%. In five cases, recanalization was not possible using
the ultrasound catheter or a variety of guide wire techniques .
Seven lesions were treated with stand-alone ultrasound
ablation; the remaining 38 lesions were treated with adjunc-
tive balloon angioplasty . In the 45 recanalized vessels, the
baseline stenosis decreased from 94 ± 10% to 55 ± 23% after
ultrasound angioplasty and to 12 ± 8% after balloon angio-
plasty .
With use of the fixed wire 2- to 3-mm probe tip, in 30 of
the 37 cases, the vessel was recanalized or the stenosis was
reduced by ?20%. The diameter stenosis was reduced from
94 ± 12% to 58 ± 23% after ultrasound ablation and to 13 ±
7% after balloon angioplasty . Figure 2 demonstrates reca-
nalization of a 12-cm long occlusion with the 2-mm ball-
tipped ultrasound probe and follow-up balloon angioplasty .
Figures 3 to 5 show the results of arterial recanalization
with the over-the-wire, monorail-type, 3-mm ball-tipped
probe. With the monorail device, slow passage of the probe
exposed each 1 cm of artery to approximately I min of
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Figure 3. Composite angiograms of
the superficial femoral artery . A,
Twelve-centimeter long superficial
femoral artery occlusion (arrows) . B,
After ultrasound recanalization with
the 2-mm ball-tipped prototype
probe. The percent diameter stenosis
after ultrasound is 75% at the narrow-
est portion of the recanalized vessel .
C, Maximal residual stenosis of 33%
after adjunctive balloon angioplasty .
ultrasound ablation . In Figure 3, the baseline angiogram has
an intraluminal filling defect indicative of a thrombotic
occlusion. This patient had developed recent and abrupt
onset of claudication . There is a marked reduction of the
stenosis by ultrasound alone, consistent with thrombus
dissolution . Figure 4 demonstrates that after treatment of a
Figure 4. A, Serial angiograms re-
veal filling defect (arrow) in the
superficial femoral artery presumed
secondary to thrombotic occlusion .
B, After passage
of the activated
over-the-wire ultrasound probe,
there is improved lumen patency at
the site of the lesion (marked by
radiopaque forceps) .
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popliteal arterial occlusion by ultrasound, follow-up balloon
angioplasty results in a larger lumen than that surrounding
the native vessel . Figure 5 shows the use of the ultrasound
catheter as a stand-alone device to treat two subtotal steno-
ses at the origin of the anterior tibial and peroneal arteries . In
arteries of this size, use of the monorail over-the-wire probe
484
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Fkare 5. Angiographic demonstration
. A, Proximal site of popliteal
artery occlusion (arrow)
. B, Site of distally patent popliteal artery
(arrow) . C, Arrow identifies site of ultrasound recanalization with
over-the-wire probe
. D, Final angiogram demonstrating patent pop-
liteal artery
: the lumen after angioplasty larger (arrow) than that of
the proximal or distal vessel,
resulted in residual angiographic stenoses of 520% . In all 13
cases in which the 3-mm over-the-wire catheter was used,
the stenosis decreased from 97 ± 5% to 44 ± 22%
. The 3-mm
over-the-wire system was used as a stand-alone device in
five cases in which the residual lumen diameter was <50%,
and there was brisk arterial runoff (mean diameter stenosis
26 ± 22%). Adjunctive balloon angioplasty was performed in
the remaining 8 cases .
Reproducibility. For each of two observers, the intraob-
server reproducibility studies yielded correlation coefficients
of r = 0.94 and r = 0.96, respectively . Linear regression
analysis for different observers also yielded a close correla-
tion (r = 0 .96) .
Comparison of the fixed and over-the-wire ultrasound
ablatloa systems . There were no significant differences in the
lesions treated with the fixed (n = 37) or over-the-wire (n =
13) probes with regard to morphology, lesion length or
percent stenosis. For the fixed-wire system (2- and 3-mm ball
tips), the mean residual stenosis in those cases treated with
subsequent balloon angioplasty was 62 ± 19% compared
with 56 ± 12% for the over-the-wire system cases treated
with adjunctive balloon angioplasty (p = NS) ; however, as
shown in Table l, after balloon angioplasty of the over-the-
wire cases, the mean residual stenosis was 0% compared
with 13 ± 7% for the non-over-the-wire cases that had
adjunctive balloon angioplasty (p < 0 .001). There were no
differences in lesion length, morphology or percent stenosis
before or after initial ultrasound treatment, but there was a
significant difference between the two groups of lesions in
the duration of exposure of the arterial wall to the sonication
process. With the over-the-wire system, arterial lesions were
exposed to ultrasound energy for I min/cm of lesion length
compared with __l5 s/cm of ultrasound energy for the
fixed-wire probe .
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Complications. The early prototype ultrasound catheters
were made with nontapered, 0 .020- to 0 .030-in . (2- to 3-mm)
ball-tipped probes. These were stiff and, as a consequence,
resulted in four mechanical arterial dissections and four
arterial pe.forations; however, these were without clinical
consequence (namely, none of these complications were
associated with bleeding, hematoma, loss of pulse or need
for surgical intervention). They occurred during advance-
ment of the stiff probe at an unfavorable oblique angle in
occluded vessels (e.g., in Hunter's canal or at a. flush
occlusion) and did not appear to be related to the use of
ultrasound energy itself but, rather, to the stiffness of the
catheter. With the advent of the recently developed flexible
ultrasound catheter system with the titanium wire tapering
from the proximal to distal end (from 0.030 [0.076 cm] to
0.024 in . [0.06 cm] or 0 .020 in . [0.051 cm]) and the use of a
monorail, over-the-wire configuration, there have been no
further peripheral arterial dissections or perforations. There
has been no angiographic or clinical evidence of distal
embolization after arterial recanalization with the fixed or
over-the-wire prototype peripheral percutaneous ultrasound
ablation devices. We have found no episodes of localized or
diffuse vasospasm at the site of ultrasound arterial recanal-
ization. Conversely, after arterial recanalization of two
different superficial femoral artery occlusions, guide-wire-
induced distal spasm occurred in two cases . In both cases, as
exemplified by Figure 6, application of the energized ultra-
Table 1. Comparison of Fixed and Over-the-Wire Ultrasound
Ablation Probes*
*Only 3? lesions were treated with adjunctive balloon angioplasty . Unless
otherwise indicated, values are presented as mean value ± SD.
Fixed
(n = 30)
Over-the-Wire
(n = 8) p Value
Probe tip size (mm) 2 or 3 3
% stenosis
Before ultrasound 94
t 12 97 ± 5 NS
After ultrasound
62 ± 19 56 ± 12 NS
After balloon angioplasty 13 ± 7 .1 0 0.001
Duration of sonicationkin (s) 15 60
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Figure 6. A, Baseline angiogram showing subtotal
occlusion of the anterior tibial and peroneal arteries
(arrows). B, After recanalization with ultrasound using
the 3-mm over-the-wire probe, the arteries are widely
patent .
sound ablation catheter resulted in reversal of the focal
vasospasm by vasodilation of the involved arterial segment
(26) . In the 1st 24 h there were no clinically evident acute
reocclusions of the 45 arteries that were patent after ultra-
sound angioplasty .
Postprocedure ankle-brachial indexes . Ankle-brachia:in-
dexes before and within 24 h after the procedure were
available in the last 33 cases. In 29 of 33 limbs, the ankle-
brachial indexes increased by >0 .10. The mean increase in
ankle-brachial index for the group studied at 24 h wn •s 0.23 ±
0.21 (range -0.27 to 0 .72) . In the seven cases with ankle-
brachial index data before the procedure and with initial
follow-up data at I month, the ankle-brachial indexes in-
creased in five cases by >0.20. Follow-up data are available
at 6 months (n = 19) and at 1 year (n = 16) for 35 patients
who were treated with ultrasound angioplasty . At 6 months,
the ankle-brachial indexes remained improved in 16 limbs
and had decreased in 3 . In the group with 1-year follow-up,
4 of 16 had deterioration of their ankle-brachial indexes,
suggesting restenosis .
Clinical follow-up. Follow-up data are available for 35
patients who were seen at 1-month, 6-month (n = 19) and
1-year (n = 16) clinical examinations . Patients were ques-
tioned as to the recurrence of claudication or overt limb
ischemia and had serial ankle-brachial indexes performed .
The 'mprovement in exercise tolerance and ankle-brachial
indexes have remained stable in 28 of 35 patients with
SIEGEL ET AL.
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>_6-month follow-up . In all cases, the decrease in ankle-
brachial index or the recurrence of clinical limb ischemia, or
both, presWnted within the I st 6 months after angiopiasty . Of
the seven patients with recurrence of symptoms or a de-
crease in ankle-brachial index, or both, no patient has
required amputation . Four of these seven patients have
angiographically documented reswnosis . In three of four,
repeat balloon angioplasty was performed, and two of these
patients subsequently underwent peripheral bypass surgery
because of recurrent symptoms .
Discussion
This clinical study of percutaneous ultrasound ablation
used to treat 50 peripheral arterial lesions extends our initial
pilot clinical study (25) and corroborates the potential utility
of this endovascular device . In this study, long occlusions
(up to 28 cm), calcific (34%) and noncalcific lesions and
presumed thrombotic occlusions were treated by ultrasound
ablation . In 86% of cases (30 of 35 lesions), s
.otal occlusions
were recanalized with the ultrasound probe . Overall, the
baseline stenosis decreased from 94 ± 10% to 55 t 23% after
ultrasound and to 12 ± 8% after balloon angioplasty .
The mean reduction in stenosis after ultrasound ablation
was 39% (range 10% to 10091b)
. Several factors appear to
affect the degree of recanalization using the ultrasound probe
alone (before or without adjunctive balloon angioplasty) .
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These include the size of the artery being treated, the size of
the ultrasound probe tip and the presence of angiographic
evidence of thrombus. Use of 3-mm probe tips in smaller
vessels (i .e .,
in four popliteal and tibioperoneal arterial
lesions) resulted in a reduction in stenosis from 100% to 20%
(n = 2), from 100% to 0% (n = 1) and from 90% to 0% (n =
1). In three cases with clinical and angiographic evidence of
a thrombotic occlusion, the residual stenosis after the use of
the 2- or 3-mm probe was s20%. In the absence of thrombus
or a method to apply the ultrasound probe in a directional
(eccentric) manner, the lumen generated approximates the
probe size, and the lumen does not appear to further increase
in size with use of the probe for >4 min at a specific site .
In the 50 lesions treated, there has been no clinical or
angiographic evidence of distal embolization nor any evi-
dence of vasospasm . By contrast, there has been evidence of
ultrasound-induced vasodilation in two ca= es with guide
wire-induced vasospasm (26). These clinical and anglo-
graphic findings are in concert with our previous in vitro and
in vivo data (8-10,12) and the findings of others (18-24) .
Although there were four arterial dissections and four arte-
rial perforations with the use of the stiff, fixed wire probes,
none of these findings had any adverse clinical sequelae .
Moreover, there were no complications with the over-the-
wire probes. On the basis of the findings of this clinical
study, the potential utility and application of ultrasound
angioplasty relate to its safety and utility as a method of
1) recanalizing occluded vessels ; 2) disrupting intraarterial
clot; 3) facilitating balloon angioplasty by altering arterial
distensibility ; and 4) potentially vasodilating arterial seg-
ments during angioplasty .
Recanalldng occluded arteries. The frequency of recanal-
ization (86%) is similar to that reported with other methods
of accessing total femoropopliteal artery occlusions,
whether using laser angioplasty (2729) . Kensey catheter
(30) or standard guide wire manipulation (31-33) . Inherent
differences in study design, patient group and lesion type and
the relatively small number of lesions treated with the fixed
or over-the-wire ultrasound probe make comparison of this
technology as a primary recanalization device with other
devices problematic. Experimental in vitro and animal stud-
ies as well as intraoperative data suggest that this method
may yield a superior recanalization rate over that of guide
wire techniques (9-11,19,21-24). However, this study was
done primarily to obtain feasibility and safety data, not to
assess superiority over guide wire techniques in peripheral
vessels. The role of the ultrasound ablation catheter system
in lesions found
kp
be guide wire resistant needs to be
determined in a larger randomized series of patients .
Tlrmabus dilution. In vitro and in vivo experimental
data incanine models have demonstrated that high intensity,
low frequency ultrasound is effective for clot dissolution
(9,11,12,16-18,24). In this clinical series, several of the
femoropopliteal lesions studied may have been due to sub-
acute thrombotic occlusions, which might explain the near
definitive recanalization seen in some lesions, even when the
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diameter of the probes used was smaller than that of the
vessel. Long occluded segments are presumed to comprise a
focal tight stenosis, with the development of retrograde and
anterograde thrombosis over an essentially near-normal ar-
tery. Thus, the experimentally observed clot dissolution
effects of ultrasound are likely to account for much of the
angiographic improvement seen in long lesions (9,11,12,16-
18,24). Differentiating the contribution of ultrasound plaque
ablation from clot disruption to the recanalization process is
probably not feasible with a clinical angiographic study .
Effects on arterial distensibility . In vitro studies using
pressure-volume curves demonstrate that distensibility of
calcific atherosclerotic arteries increases after exposure to
the type of high intensity, low frequency ultrasound used in
this study (13). Use of the over-the-wire probe with exposure
of the artery to ultrasound energy of 1 cm/min resulted in a
final residual stenosis after balloon angioplasty of 0% com-
pared with 13 17% (p < 0.001) for the arteries pretreated
with the non-over-the-wire system and an exposure rate of
<15 s/cm (Table 1) . This difference occurred despite the
findings that the mean residual stenosis after ultrasound
angioplasty with the over-the-wire probe (56 ± 12%) was
essentially the same as that after use of the non-over-the-
wire system (62 ± 19%, p = NS) . It is likely that the
observed difference is due to the more prolonged exposure
to ultrasound-enhancing arterial distensibility and subse-
quent additional dilation by balloon angioplasty (13) .
High speed rotational atherectomy (Rotablator) (34,35),
thermal laser angioplasty (36,37) and balloon angioplasty
(38) have all been associated with arterial vasospasm, which
may be more problematic in the popliteal and infrageniculate
arteries. None of the patients that we studied were pre-
treated with nitrates or calcium channel blocking agents . We
encountered no cases of arterial vasoconstriction at the site
of ultrasound recanalization . In two cases with distal guide
wire-induced spasm, the ultrasound probe was effectively
used to treat the focal vasospasm, with rapid resolution of
vasoconstriction and improved anterograde angiographic
flow (26) . This observation is consistent with previous find-
ings by Fischell et al . (14) . They demonstrated in whole
perfusel rabbit aortas as well as in an in vivo canine model
that ultrasound induces arterial relaxation that is indepen-
dent of the presence or absence of the endothelium . An
angioplasty device that promotes vasodilation may be clini-
cally beneficial because vasoconstriction after recanalization
could promote turbulent flow with high shear rates, aug-
mented platelet aggregation, thrombus formation and abrupt
closure . Of note, no patient in this series had abrupt closure
(s24 h) of the treated arterial lesions.
Clinical restenesb. To date, devices being used for periph-
eral arterial recanalization and reduction in arterial stenoses
have a restenosis rate that ranges from 20% to 62% (28-33) .
Six- to 12-month follow-up data are available for 35 patients
who underwent ultrasound ablation followed by adjunctive
balloon angioplasty. In 28 lesions (80%) there has been no
evidence of restenosis, whereas in 7 (20%) the follow-up
IACC Vol . 22, No . 2
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ankle-brachial indexes have worsened . Four of these seven
patients have angiographically documented restenosis, and
three of the four have undergone either balloon angioplasty
or peripheral bypass surgery . Clinical and ankle-brachial
index follow-up may result in an underestimation of resten-
osis (due to collateral blood flow) or overestimation of
restenosis (due to progression of vascular disease at proxi-
mal or distal sites) . In this report on ultrasound angioplasty,
the largest clinical series to date, there were too few patients
treated and insufficient angiographic or Doppler color flow
follow-up data to make any meaningful assessment of the
restenosis rate (28-33) .
Study limitations . The series of patients reported here
represents the largest cohort of patients treated with percu-
taneous peripheral ultrasound angioplasty (45 patients, 50
lesions) ; however, owing to the small number of patients
treated, the use of two probe types (over-the-wire and fixed
wire devices) as well as the absence of a central core
laboratory for angiographic analysis, definitive conclusions
on device utility are limited . In addition, follow-up data are
limited by the lack of preprocedure ankle-brachial indexes in
10 of the 50 cases; however, on the basis of the positive
findings in this pilot study, we suggest that a multicenter
study with randomization to ultrasound angioplasty with or
without adjunctive balloon angioplasty should bt:' compared
with standard balloon angioplasty to obtain definitive data on
the merits of peripheral ultrasound angioplasty versus stan-
dard peripheral balloon angioplasty .
Summary . Our clinical experience in 45 patients with 50
peripheral arterial lesions indicates that percutaneous ultra-
sound angioplasty is feasible . Our clinical findings are con-
sistent with the experimental in vitro and animal studies
demonstrating that catheter-delivered ultrasound is rela-
tively atraumatic to the normal arterial wall, causes localized
vasodilation, appears to enhance arterial distensibility and
debulks arterial lesions by plaque ablation or thrombus
dissolution, or both, and does not generate detectable emboli
in the patient group studied (70% total occlusions) . Initial
results are encouraging, with no clinical manifestations of
reocclusion at 24 h and a high (80%) 6- to 12-month patency
rate. Further studies will be undertaken in the peripheral and
coronary arteries to compare the potential benefits with
regard to the short- and long-term outcome of this new
technique with results of standard balloon angioplasty .
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